Author: Lior Ishai

Home / Articles posted by Lior Ishai (Page 2)

BERLIN, DEUTSCHLAND, 3. Mai 2019 | Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (FSE: C4T) kündigt an, dass eigene, stimmberechtigte Stammaktien an der Frankfurter Börse (FSE) unter dem Handelszeichen "C4T" (WKN: A12DYZ, ISIN: CA16961T2083) gehandelt werden können. Im Rahmen der Marktpflege repräsentiert die Baader Bank AG Chinook in Deutschland. “Europa wird absehbar innerhalb der kommenden fünf Jahre der größte Markt für legales Cannabis werden, da in Europa mehr als 740 Millionen Menschen beheimatet sind und hier die Bevölkerung mehr als doppelt...

BERLIN, GERMANY, May 3rd, 2019 | Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (FSE: C4T) is pleased to announce that its Class A Voting Common Shares will be listed for trading on the Frankfurt Stock Exchange (FSE), also known as Börse Frankfurt, under the trading symbol "C4T" (WKN: A12DYZ, ISIN: CA16961T2083). The market maker representing Chinook in Germany is Baader Bank AG. "Europe is set to become the world's largest legal cannabis market over the next five years as it is home to more than 740...

ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ - AMP Alternative Medical Products GmbH ("AMP"), a subsidiary of Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), has entered into a non-binding Memorandum of Understanding Production Supply Agreement ("MOU") with Pure Life Cannabis Corporation ("PLCC"), a late-stage Health Canada applicant to become a licensed producer of cannabis ("LP") based in Edmonton, Alberta. PLCC is in the process of building a 27,280 square foot Phase 1 facility, which it anticipates can produce approximately 2,000 kilograms of EU-GMP cannabis flower annually and...

BERLIN, Feb. 5, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment finance company with two European subsidiaries, AMP Alternative Medical Products GmbH based in Erfurt, Germany and Mercury Partners & Company plc based in Valletta, Malta. Chinook has 10,217,796 fully diluted shares issued and outstanding and net investment assets of over $2.0 million (unaudited) as of September 30th, 2018. About AMP Alternative Medical Products ("AMP")AMP Alternative Medical Products GmbH, is a biopharmaceutical company based in the German state of Thuringia and provides medical cannabis formulations and...

ERFURT, Germany, Dec. 3, 2018 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) announces that AMP Alternative Medical Products GmbH ("AMP"), its wholly-owned subsidiary, has entered into a €500,000 Series B drawdown loan facility provided by Taiga Atlas plc ("Taiga Atlas").  AMP completed a €75,000 Series A equity financing with Chinook during 2018. AMP is a German based biopharmaceutical company developing medical cannabis formulations and dose delivery systems for patients in Germany.  Proceeds from the financing will be used to build out AMP's German sales and distribution supply...